Restoring the regulatory regime in IBD: Do anti-TNF agents rescue treg?

Inflammatory Bowel Diseases

Volumn 18, Issue 6, 2012, Pages 1186-1187

  Heetun, Zaid ^a   Doherty, Glen A ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CASPASE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

APOPTOSIS; BLOOD; CROHN DISEASE; ENTERITIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; IMMUNOCHEMISTRY; INTESTINE BIOPSY; MICROSCOPIC COLITIS; MUCOSA INFLAMMATION; NICK END LABELING; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 84861337921     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21876     Document Type: Note

References (8)

1. Wildin RS, Smyk-Pearson S, Filipovich AH,. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002; 39: 537-545.
2. Saruta M, Yu QT, Fleshner PR, et al. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol. 2007; 125: 281-290.
3. Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005; 128: 1868-1878.
4. Veltkamp C, Anstaett M, Wahl K, et al. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNF{alpha} treatment. Gut. 2011 [Epub ahead of print].
5. Boschetti G, Nancey S, Sardi F, et al. Therapy with anti-TNFalpha antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis. 2011; 17: 160-170.
6. Li Z, Arijs I, De Hertogh G, et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. Inflamm Bowel Dis. 2010; 16: 1299-1310.
7. Dwyer KM, Hanidziar D, Putheti P, et al. Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant. 2010; 10: 2410-2420.
8. Hovhannisyan Z, Treatman J, Littman DR, et al. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2011; 140: 957-965.